Development of a Hypoallergenic Recombinant Parvalbumin for First-in-Man Subcutaneous Immunotherapy of Fish Allergy
Author(s) -
Laurian Zuidmeer,
H. Huber,
Ines Swoboda,
Neil M. Rigby,
Serge A. Versteeg,
Bettina M. Jensen,
Suzanne Quaak,
Jaap H. Akkerdaas,
Lars Blom,
Juan A. Asturias,
Carsten BindslevJensen,
Maria Livia Bernardi,
Michael Clausen,
Rosa Ferrara,
Martina Hauer,
Jet Heyse,
Stephan Kopp,
Marek L. Kowalski,
Anna LewandowskaPolak,
Birgit Linhart,
Bernhard Maderegger,
Bernard Maillère,
Adriano Mari,
Alberto Martı́nez,
E. N. Clare Mills,
Angela Neubauer,
Claudio Nicoletti,
Nikolaos G. Papadopoulos,
Antonio Portolés,
Ville RantaPanula,
S. SantosMagadán,
Heidi Julius Schnoor,
Sigurveig Sigurdardottir,
Per Stahl Skov,
George Stavroulakis,
Georg Stegfellner,
Sonia VázquezCortés,
Marianne Witten,
Frank Stolz,
Lars K. Poulsen,
Montserrat FernándezRivas,
Rudolf Valenta,
Ronald van Ree
Publication year - 2015
Publication title -
international archives of allergy and immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.696
H-Index - 100
eISSN - 1423-0097
pISSN - 1018-2438
DOI - 10.1159/000371657
Subject(s) - hypoallergenic , immunogenicity , basophil activation , allergy , allergen , pharmacology , immunology , medicine , recombinant dna , chemistry , immune system , immunoglobulin e , antibody , biochemistry , basophil , gene
The FAST (food allergy-specific immunotherapy) project aims at developing safe and effective subcutaneous immunotherapy for fish allergy, using recombinant hypoallergenic carp parvalbumin, Cyp c 1.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom